News Focus
News Focus
icon url

Hold10

02/24/23 4:58 PM

#217716 RE: misiu143 #217714

you say Arman "seems to have a plan". What you LOLngs don;t understand at all is that there is no money and there is no contingency for money and therefore no "plan" can be executed. No one knows how an arbiter might rule and there are no partnerships possible at all for several years at least. Arman has told you repeatedly that there won;t be any partnership interest until they can complete a new trial and show unequivocal results. NO ONE partners with a company whose management team consists of 3 pharma people who have never managed a trial together. NO ONE partners with a company with as much as $100,000,000 subject to injunctive relief. Those 2 matters are 1000% disqualifying. Big pharma absolutely throws money at bad prospects all the time, but they aren;t going to purposely burn their money or flush it down the toilet.
icon url

Blueheel1

02/25/23 9:09 AM

#217728 RE: misiu143 #217714

There are a few things that will happen in 2023:

1. The hold will be lifted likely in the next one to two weeks. All of the data was submitted to the FDA more than three weeks ago and they have 30 days to respond. From what I know about Cyrus, it was done thoroughly and completely.

2. Once the hold is lifted, we will attract a partner to fund our trials in oncology.

3. The company will re-brand with a new name which makes perfect sense. The old leadership that nearly ran this company into the ground is completely gone and this is a totally new team, focused on different indications, etc. – – effectively a new company with the same extremely promising drug.

4. We will, indeed receive a significant amount of money from Amarex this year – – the case against them is very clear cut.

5. A large NASH trial will be initiated and we will make progress toward enrollment. We will be one of several companies that make a ton of money in this massive market.

I have been invested for seven years and became extremely negative and disillusioned during the last year of Nader’s leadership. I voiced those concerns publicly, but finally decided to simply keep my mouth shut, as I am generally a positive person.

But we are in a completely different ballgame now. Cyrus is all business / no BS - the real deal. I know this from direct experience.

No, I won’t respond to any of the troll comments that I’m sure I will get from this post – – because I know a lot more about what is going on behind the scenes than any of them do, and they are likely employed by short-sellers anyway. but to be very clear, we are close to a value inflection point here as we finally have world class leadership paired with a world class drug.

Good luck longs. 2023 is (finally) our year.